[Treatment of intestinal amebiasis with chloroquine with bismuth glycolylarsanilate and with fumagillin].
D000562:Amebiasis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use*; D003510:Cyclohexanes; D004404:Dysentery, Amebic / Q000628:therapy*; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes
D000900:Anti-Bacterial Agents; D001152:Arsenicals; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; C026211:fumagillin; D002738:Chloroquine; D001729:Bismuth
AMEBIASIS, INTESTINAL/therapy; ANTIBIOTICS/therapeutic use; BISMUTH-ARSENIC COMPOUNDS/therapeutic use; CHLOROQUINE/therapeutic use
Tratamiento de la amebiasis intestinal con cloroquina-glicolil-arsanilato de bismuto y fumagilina.